PrimeVigilance announces their next webinar which will be co-hosted by Pharmafocus and features speaker Dr. Cvijeta Bielen PrimeVigilance Medical Director. This session takes place on Thursday 15th of March, 2018 starting at 3 pm GMT (UK), 4 pm CET (Europe), 11 am EDT (US). Dr. Bielen will provide practical advice on the following hot topic: EVDAS outputs are available to MAHs – what now ?

Key topics covered in this webinar include:

• How to plan signaling frequency
• What sources of data need to be considered
• What best to focus on during signal detection vs. signal evaluation reviews
• The robust documentation of activities

Finally this webinar will focus on giving the listeners a comprehensive overview of all the new regulatory requirements for products on an additional monitoring list, and some last-minute additional requirements for other products that were not expected to be impacted by EVDAS during 2018.

The webinar will be followed by a Q&A session where you will be able to ask questions and receive direct feedback on key areas of uncertainty.

Click here to book your place today. If you require further information, please do not hesitate to contact us.

Share this:




This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

Privacy Settings saved!
Cookie Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

  • __cfduid

Decline all Services
Accept all Services